These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 14227805)
21. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES. WOLINSKY E Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093 [No Abstract] [Full Text] [Related]
22. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS. VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913 [No Abstract] [Full Text] [Related]
23. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI]. TSUCHIMOCHI T Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673 [No Abstract] [Full Text] [Related]
24. [TREATMENT OF TUBERCULOSIS AND DIABETES BECOMING SIMILAR]. DEENSTRA H Ned Tijdschr Geneeskd; 1964 Feb; 108():397-8. PubMed ID: 14135827 [No Abstract] [Full Text] [Related]
26. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS]. SZENDROEI Z; CSERNUS A Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677 [No Abstract] [Full Text] [Related]
27. [COMPARISON OF A DETERMINATION OF DRUG RESISTANCE USING 1 PER CENT OGAWA MEDIUM AND LOEWENSTEIN-JENSEN MEDIUM (EXAMINATION OF SPUTUM)]. TSUKAMURA S Kekkaku; 1964 Feb; 39():60-3. PubMed ID: 14136876 [No Abstract] [Full Text] [Related]
28. A CONTROLLED CLINICAL TRIAL OF ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE IN PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS. BOESZOERMENYI M; FAUSZT I; BARAT I; SCHWEIGER O Tubercle; 1965 Jun; 46():143-50. PubMed ID: 14327962 [No Abstract] [Full Text] [Related]
29. FURTHER OBSERVATIONS ON THE KANAMYCIN RESISTANCE IN TUBERCULOUS PATIENTS. TSUKAMURA M; KASAI E; TSUKAMURA S Jpn J Tuberc; 1964 Jul; 12():27-33. PubMed ID: 14178489 [No Abstract] [Full Text] [Related]
30. [The importance of medical treatment of pulmonary tuberculosis from a new viewpoint]. HEYMER A Internist (Berl); 1962 Oct; 3():574-85. PubMed ID: 13954331 [No Abstract] [Full Text] [Related]
32. [OUR RESULTS IN CHEMO-ANTIBIOTIC THERAPY OF SILICOTUBERCULOSIS]. GRECO S; MUSSOMELI A Med Lav; 1963 Mar; 54():208-13. PubMed ID: 14115101 [No Abstract] [Full Text] [Related]
33. DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS. MEDINA G; CHAPMAN PT Dis Chest; 1965 Feb; 47():146-52. PubMed ID: 14261185 [No Abstract] [Full Text] [Related]
34. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM]. FILLA E; COMENALE D; ROSSI F Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139 [No Abstract] [Full Text] [Related]
35. RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS. PFUETZE KH; PYLE MM JAMA; 1964 Mar; 187():805-10. PubMed ID: 14094316 [No Abstract] [Full Text] [Related]
36. CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS. MOODIE AS; SISTER AQUINAS ; FOORD RD Tubercle; 1964 Sep; 45():192-201. PubMed ID: 14227804 [No Abstract] [Full Text] [Related]
39. ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. CONN HO; BINDER HJ; ORR HD Am Rev Respir Dis; 1964 Oct; 90():542-52. PubMed ID: 14221666 [No Abstract] [Full Text] [Related]
40. [DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST]. KALICH R; GERLOFF W; KREBS A; SCHMIEDEL A Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1965 Jan; 129():353-69. PubMed ID: 14273020 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]